Showing all 10 results
Entacavir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Microdose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical stability of the potent antiviral API.
Active Ingredient Strength Primary Clinical Function Entecavir (as Monohydrate) USP/Ph.Eur. 0.5 mg The Global Nucleoside-Naive Standard: The definitive ultra-micro-dose utilized for the daily, lifelong suppression of HBV in patients who have never received prior antiviral therapy. Entecavir (as Monohydrate) USP/Ph.Eur. 1.0 mg The Refractory & Cirrhosis Standard: Double-strength therapeutic payload utilized specifically for patients with Lamivudine-resistant HBV viremia or those suffering from decompensated liver cirrhosis. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Crospovidone / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Lubricant / Film-Coating (Engineered specifically utilizing advanced multi-stage geometric dilution to ensure the microscopic 0.5mg payload is flawlessly distributed throughout the tablet matrix, preventing toxic “hot spots” or sub-therapeutic failures) *Pack Sizes: 3×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic hepatology dispensing regimens).
Ledipasvir & sofosbuvir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Dual-Active FDC Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles with specialized desiccants to ensure the absolute chemical survival of the complex antiviral APIs.
Active Ingredient Strength Primary Clinical Function Ledipasvir USP/Ph.Eur. 90 mg The NS5A Anchor: Potent inhibitor of viral assembly and secretion; highly effective against specific HCV genotypes. Sofosbuvir USP/Ph.Eur. 400 mg The NS5B Backbone: The globally recognized foundational DAA that forces viral RNA chain termination across multiple genotypes. Excipients Copovidone / Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate / Premium Opadry Film Binder / Diluent / Superdisintegrant / Lubricant / Film-Coating (Engineered specifically to solve the massive solubility differences between the highly soluble Sofosbuvir and the poorly soluble Ledipasvir, guaranteeing synchronized gastric release and peak systemic absorption) *Pack Sizes: Bottles of 28 (Optimized specifically for the strict 4-week dispensing intervals required for 8, 12, or 24-week curative regimens).
Ledipasvir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Solid-Dispersion Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical survival of the complex antiviral API.
Active Ingredient Strength Primary Clinical Function Ledipasvir USP/Ph.Eur. 90 mg Global Hepatology Standard: The definitive daily dose required to maintain constant, paralyzing pressure on the NS5A viral protein across the entire 12-to-24 week curative cycle. Excipients Copovidone / Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate / Premium Opadry Film Solubility Enhancer / Diluent / Superdisintegrant / Lubricant / Film-Coating (Engineered specifically utilizing Amorphous Solid Dispersion techniques with Copovidone to force the highly insoluble Ledipasvir to dissolve instantly in gastric fluid, guaranteeing maximum systemic bioavailability) *Pack Sizes: Bottles of 28 or 10×10 Blisters (Optimized specifically for strict 4-week dispensing intervals to match custom DAA combination regimens).
Liv 52 tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Standardized Herbal Matrix Tablet, packed exclusively in highly secure, moisture-resistant PVC/PVDC or Alu-Alu blister strips to ensure the absolute chemical stability of the highly oxidative botanical alkaloids.
Standardized Botanical Extract Target Biomarker Primary Clinical Function Milk Thistle Ext. (Silybum marianum) Standardized to 70% Silymarin (140 mg) The Antioxidant Anchor: Massive glutathione restoration and hepatocyte membrane stabilization. Andrographis paniculata (Kalmegh) Ext. Standardized to 10% Andrographolides The Choleretic Catalyst: Potent antiviral properties (Hepatitis) and violent stimulation of bile flow to flush out hepatic toxins. Phyllanthus niruri (Bhumyamalaki) Ext. Standardized Bitters The Viral Blocker: Clinically documented to suppress the replication of the Hepatitis B virus and protect against drug-induced liver injury (DILI). Boerhavia diffusa (Punarnava) Ext. Standardized Alkaloids The Hepatic Diuretic: Reduces liver enlargement (hepatomegaly) and flushes out excess fluid accumulation (ascites) caused by liver failure. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Moisture-Barrier Film Diluent / Superdisintegrant / Glidant / Film-Coating (Engineered specifically to lock out atmospheric moisture—which destroys botanical extracts—and completely mask the intensely bitter taste of Kalmegh and Silymarin) *Pack Sizes: Bottles of 100 or 10×10 Blisters (Optimized specifically for strict 3-to-6 month chronic hepatology dispensing regimens).
Ribavirin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or heavy-density PVC/PVDC blister strips to ensure the stability of the active nucleoside analog and protect handlers from exposure.
Active Ingredient Strength Primary Clinical Function Ribavirin USP/Ph.Eur. 200 mg Global Clinical Standard: Base titration unit for precise, weight-based antiviral dosing. Ribavirin USP/Ph.Eur. 400 mg High-dose unit to drastically improve pill-burden compliance in heavy patients. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone / Magnesium Stearate Diluent / Superdisintegrant / Binder (Engineered for immediate gastric dissolution and rapid systemic absorption) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for high-dose, weight-based daily regimens requiring 4 to 6 tablets per day).
Rifaximin Ph.Eur Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of the crystalline polymorph structure.
Active Ingredient Strength Primary Clinical Function Rifaximin Ph.Eur. 200 mg / 400 mg GI Infection Dose: Acute eradication of non-invasive E. coli (Traveler’s Diarrhea). Rifaximin Ph.Eur. 550 mg Hepatology & IBS Standard: High-dose maintenance therapy for Hepatic Encephalopathy and IBS-D. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Colloidal Silicon Dioxide / Propylene Glycol Diluent / Superdisintegrant / Glidant / Film-Coating Plasticizer (Engineered for optimal dispersion throughout the intestinal lumen) *Pack Sizes: 10×10 Alu-Alu Blisters or 14-Tablet Blisters (Optimized specifically for standard acute infection or chronic hepatology dispensing regimens).
Silymarin 140 mg Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet or Hard Gelatin Capsule, packed in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to preserve the integrity of the highly sensitive botanical extract.
Active Ingredient Strength Primary Clinical Function Silymarin (Standardized Extract) BP/Ph.Eur. 140 mg (Calculated as Silybin) Global Clinical Standard: High-dose therapeutic management of acute and chronic liver damage. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone / Magnesium Stearate Diluent / Superdisintegrant / Binder (Engineered for optimal gastric dissolution and maximized gastrointestinal absorption of the flavonolignans) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 30-to-90 day chronic hepatology adherence regimens).
Sofosbuvir 400 mg tablet + Ledipasvir 90 mg Tablet
FreeA tablet containing Sofosbuvir 400 mg + Ledipasvir 90 mg is a fixed-dose combination antiviral medication used to treat chronic Hepatitis C Virus (HCV) infection, specifically targeting genotypes 1, 4, 5, and 6.
Sofosbuvir 400mg+ Velpatasvir 100 mg Tablet
FreeA Sofosbuvir 400 mg + Velpatasvir 100 mg tablet is a fixed-dose combination antiviral medication used to treat chronic Hepatitis C Virus (HCV) infection across all major genotypes (1 through 6).
Sofosbuvir Tablet
FreeA Sofosbuvir 400 mg tablet is a direct-acting antiviral medication used to treat chronic Hepatitis C Virus (HCV) infection. It belongs to the nucleotide polymerase inhibitor class and works by blocking the NS5B protein, which the virus needs to replicate.
